Parallax Volatility Advisers’s Abiomed Inc ABMD Stock Holding History

Parallax Volatility Advisers’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,601	Closed	-$998K	–	3291
2020 Q3	$998K	Buy	3,601 +2,303	+177%	+$663K	﹤0.01%	1986
2020 Q2	$314K	Sell	1,298 -12,446	-91%	-$2.5M	﹤0.01%	2127
2020 Q1	$2M	Buy	+13,744	New	+$2.28M	﹤0.01%	1235
2019 Q3	–	Sell	-69	Closed	-$18K	–	3740
2019 Q2	$18K	Sell	69 -17,753	-100%	-$4.71M	﹤0.01%	2104
2019 Q1	$5.09M	Buy	17,822 +16,763	+1,583%	+$5.57M	0.01%	689
2018 Q4	$344K	Buy	+1,059	New	+$368K	﹤0.01%	1604
2018 Q3	–	Sell	-3,619	Closed	-$1.43M	–	3843
2018 Q2	$1.48M	Buy	+3,619	New	+$1.31M	﹤0.01%	990

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Parallax Volatility Advisers's ABMD Position: Q4 2020 in Review

Parallax Volatility Advisers sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 3,601 shares — an estimated $998K sold.

Parallax Volatility Advisers first reported a position in ABMD in Q2 2018 and held it in 7 quarters. The position peaked at $5.09M in Q1 2019. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

Parallax Volatility Advisers reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
Parallax Volatility Advisers sold 3,601 Abiomed Inc shares in Q4 2020, an estimated $998K.
Parallax Volatility Advisers first reported a position in Abiomed Inc in Q2 2018 and held it in 7 quarters.
Parallax Volatility Advisers's Abiomed Inc position peaked at $5.09M in Q1 2019.
498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Parallax Volatility Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.